A review of eslicarbazepine acetate (Stedesa®)

Eslicarbazepine acetate is an anticonvulsant medication approved in Europe for adjunctive therapy in adults with partial-onset seizures. FDA approval is expected shortly for use in the United States. This article reviews the pharmacologic and pharmacokinetic profile of eslicarbazepine acetate, and f...

Full description

Saved in:
Bibliographic Details
Published in:The mental health clinician 2012-11, Vol.2 (5), p.111-114
Main Authors: Price, Cristofer, Ryan, Melody
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Eslicarbazepine acetate is an anticonvulsant medication approved in Europe for adjunctive therapy in adults with partial-onset seizures. FDA approval is expected shortly for use in the United States. This article reviews the pharmacologic and pharmacokinetic profile of eslicarbazepine acetate, and factors that should be considered when using this medication.
ISSN:2168-9709
2168-9709
DOI:10.9740/mhc.n127372